These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31755476)

  • 1. Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma.
    Ucan Gunduz G; Gelisken O; Yalcinbayir O; Guler K
    Indian J Ophthalmol; 2019 Dec; 67(12):2104-2106. PubMed ID: 31755476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab, photodynamic therapy, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma.
    Fong AH; Li KK; Wong D
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):625-7. PubMed ID: 20676670
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.
    Agarwal A; Kumari N; Singh R
    Int Ophthalmol; 2016 Oct; 36(5):747-50. PubMed ID: 26815929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
    Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
    Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
    Mennel S; Meyer CH; Callizo J
    Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy-Assisted Excision in the Treatment of Juxtapapillary Retinal Capillary Hemangioma.
    Parra MM; Arias JD; Viteri EJ; Bolivar I; Vega LY; Hartnett ME
    Ophthalmic Surg Lasers Imaging Retina; 2022 Oct; 53(10):570-573. PubMed ID: 36239674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
    Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
    Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Use of anti-VEGF preparations and PDT in the treatment of retinal juxtapapillary hemangioma - a case report].
    Matušková V; Vysloužilová D
    Cesk Slov Oftalmol; 2014 Oct; 70(5):196-200. PubMed ID: 25640043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars plana vitrectomy for juxtapapillary capillary retinal angioma.
    Kreusel KM; Bechrakis NE; Neumann HP; Foerster MH
    Am J Ophthalmol; 2006 Mar; 141(3):587-9. PubMed ID: 16490522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JUXTAPAPILLARY CAPILLARY RETINAL ANGIOMA AND EPIRETINAL MEMBRANE MANAGEMENT IN A MONOCULAR PATIENT WITH VON HIPPEL-LINDAU SYNDROME.
    Schönbach EM; Trichonas G
    Retin Cases Brief Rep; 2022 Jul; 16(4):520-522. PubMed ID: 32541428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juxtapapillary capillary hemangioma treated by intravitreal injection of bevacizumab combined with posterior subtenon injection of triamcinolone acetonide.
    Toyokawa N; Kimura H; Kuroda S
    Jpn J Ophthalmol; 2010 Mar; 54(2):168-70. PubMed ID: 20401570
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Results of Various Treatments for Retinal Capillary Hemangioma.
    Won YK; Lee MW; Shin YI; Kim JY; Jo YJ
    Korean J Ophthalmol; 2020 Apr; 34(2):133-142. PubMed ID: 32233147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Juxtapapillary capillary retinal angioma with epiretinal membrane of the macula in familial Von-Hippel-Lindau-Syndrome].
    Kreusel KM; Bechrakis NE; Neumann HP; Foerster MH
    Ophthalmologe; 2007 Apr; 104(4):317-20. PubMed ID: 17123050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with intravitreal bevacizumab injection and photodynamic therapy for juxtapapillary retinal capillary haemangioma.
    Zubicoa A; Andonegui J; Compains E; Plaza P; Tabuenca L; Mozo M
    J Fr Ophtalmol; 2020 Apr; 43(4):e139-e141. PubMed ID: 32111502
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W; Kase S; Ohgami K; Mori S; Ohno S
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of juxtapapillary retinal capillary hemangioma].
    Li J; Xiao J; Liang JH
    Zhonghua Yan Ke Za Zhi; 2019 Aug; 55(8):609-615. PubMed ID: 31422640
    [No Abstract]   [Full Text] [Related]  

  • 17. Von Hippel-Lindau Incidentally Diagnosed in Evaluation of Sporadic Aniridia.
    Holmen IC; Oakey Z; Altaweel MM
    Ophthalmology; 2018 May; 125(5):663. PubMed ID: 29681293
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane.
    Kimura S; Morizane Y; Toshima S; Hosogi M; Kumase F; Hosokawa M; Shiode Y; Fujiwara A; Shiraga F
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1731-6. PubMed ID: 26951250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membrane peeling combined with intravitreal injection of bevacizumab for treatment of macular epiretinal membrane: analysis of 33 cases].
    Li Z; Zhang G; Su K; Song X; Tian R; Gu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1207-9. PubMed ID: 25176098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma.
    Russo V; Stella A; Barone A; Scott IU; Noci ND
    Int Ophthalmol; 2012 Feb; 32(1):71-5. PubMed ID: 22271068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.